3rd international Conference on new therapies for Parkinson and Alzheimer diseases (IPAD 3)
Pisa, Italy
September 18-19, 2015 The 3rd International Conference on New Therapies for Dementia and Parkinsonian Syndromes will take place in Pisa on September 18 and 19,… Continue Reading

The “Presidential Plenary Symposium: Hot topics in neurological sciences” is available as webcast now! Go to www.eaneurology.org and log in with your username and password. You will find the following four lectures under “e-Education”: Xavier Montalban: Translational research for biomarkers… Continue Reading

Elena Moro (EM):  Can you briefly introduce the Alliance for Biomedical Research in Europe (BioMed Alliance) to the Neuropenews readers? Karin Sipido (KS): The Alliance for Biomedical Research in Europe (BioMed Alliance) is a unique initiative representing 21 leading European biomedical societies that together include more than 400,000 researchers and health professionals across Europe.

Elena Moro (EM): The EAN Quality Assurance Sub-Committee works closely together with the EAN Education Committee. Can you briefly describe the main reasons why the EAN has gathered this sub-committee? Jan Kuks (JK): In fact, the EAN Quality Assurance sub-Committee is part of the EAN Education Committee (EC). We are working together with the main board of the EC and other EC-subcommittees (such as the Teaching Course sub-Committee), to set up an optimal programme for teaching and education, offered to the European neurological community by the EAN.

Did you miss out on teaching courses you’d like to have attended at the first EAN congress in Berlin, June 2015?
Fear not – almost all are now also available for EAN members via the ebrain platform at http://www.ebrainjnc.com/learning/course/category.php?id=56. In… Continue Reading

by Delia Lenzi A very interesting article by Joseph LeDoux (Center for Neural Science at NYU) explains why amygdala is not the centre of fear. He then focuses on the well known problem in neuroscience that is speculative interpretation of… Continue Reading

For September 2015 we have selected: The Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 2015;372:2481-2498. There are currently several limitations with the histopathological classification of lower-grade gliomas, mainly related to high interobserver variability and insufficient prediction of clinical outcome.

Report from Maliia Dragos Mihai from Romania visiting the University-Hospital Freiburg, Center for Epilepsy in Freiburg, Germany under the supervision of Professor Schulze-Bonhage. My name is Maliia Dragos Mihai and I am a neurology resident in Bucharest, at Universitary Emergency… Continue Reading

  by Claudia Sommer   Building on successes in Berlin this summer, you will soon see, particularly from 2017 onwards, new formats being introduced at the annual EAN meetings. First of all, the main symposia will not be changed. Here, exciting… Continue Reading

All e-learning activities are free-of-charge for EAN members registered to www.eaneurology.org !
Answer all questions correctly and you will receive one hour of CME. European Journal of Neurology
Every month one article is chosen for online learning. The following articles… Continue Reading

In this issue of the Neuropenews, our Subspecialty Scientific Panel Sleep-wake disorders invites you to read an article on Alzheimer’s disease: “Alzheimer’s disease (AD) is the most frequent dementia. Sporadic AD is thought to be due, in part, to impaired… Continue Reading

The 1st Congress of the European Academy of Neurology, held in Berlin, June 20-23, 2015, was attended by a total of 6391 participants. About 2500 (39,11%) attendees filled in the survey to receive their certificate of attendance (in Istanbul 24%… Continue Reading

… is online now! Click here to read.

Elena Moro (EM): We congratulate you on your appointment as new Chair of the MDS-European Section. Which role do you expect the MDS-European Section to cover within the EAN and the European neurology world? How do you foresee the cooperation between the MDS-ES and the EAN? Which main joint educational initiatives would you particularly promote and why? Joaquim Ferreira (JF): First I would like to start by congratulating the EAN and its Board for the success of the first congress in Berlin. The founding of the EAN is a major achievement for the world of neurology and will have positive implications that will reach beyond European borders. I would also like to extend my compliments to all stakeholders who had the vision and the generosity to contribute to this major cause.

Elena Moro (EM): As Chair of the Education Committee, can you illustrate the role you give to EAN within the community of European neurologists? Hannah Cock (HC): I see my role as leading on the Educational Strategy of the EAN, and overseeing the delivery of educational activities to support this, in parallel with ensuring robust quality assurance mechanisms are in place. Education underpins much of the EAN vision, and is also a substantial component of the annual budget so this is a role I take very seriously, working closely with my colleagues on the board and of course the committee and subcommittees.